Article Text

Download PDFPDF

B176 Lornoxicam as a treatment of geriatric golden age female patients with chronic neck pain
  1. N Syrmos1,
  2. S Κaratzoglou2,
  3. P Christoglou2,
  4. S Kottas2,
  5. E Logotheti3,
  6. V Giannouli1 and
  7. A Mylonas1
  1. 1Aristotle University, Thessaloniki, Greece
  2. 2Papanikolaou General Hospital, Thessaloniki, Greece
  3. 3General Hospital, Volos, Greece


Background and Aims Aim-Aim of this study was to evaluate the use of use of meloxicam in geriatric golden age patients (>80 years old) female patients, with chronic neck pain.

Methods Material and Methods- 10 female geriatric golden age patients were participated in this study. For 14 days (2 weeks) they receive 8 mg lornoxicam, two times a day. Range of age 82–94 years and mean age 85 .

We used specific performance pain tests in order to evaluate our results.

Results 9 of them (90%) reported optimal results and good reaction to the treatment. 1 of them (10%) reported moderate results and mild reaction to the treatment.

Conclusions We need more patients but this therapeutic path seems to be an optimal and safe treatment , specially for golden age elderly female patients with chronic neck pain.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.